Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03105271 · ClinicalTrials.gov registry record
Acute Kidney Injury in Patients With Sickle Cell Disease
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 60
- Enrollment target
NCT03105271: Completed study, sponsored by University of Alabama at Birmingham.
NCT03105271 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03105271 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Patients with sickle cell disease may be at risk for acute kidney injury (AKI)during sickle cell crisis (pain or acute chest syndrome). This study will evaluate the role of hemolysis during SCD crisis on the development of AKI and the role for monitoring urine biomarkers during an admission for crisis and during well clinic follow-up.
Primary Outcome
Evaluate the incidence of KDIGO defined AKI among patients admitted for pain or acute chest syndrome. AKI is defined by KDIGO as an increase in SCr by 50% or ≥0.3mg/dL from baseline, or UOP \<0.5mL/kg/hr for 12 hrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2022-01-31 |
What the finished NCT03105271 record still lists
NCT03105271 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03105271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03105271 about?
NCT03105271 is a clinical study titled "Acute Kidney Injury in Patients With Sickle Cell Disease". Patients with sickle cell disease may be at risk for acute kidney injury (AKI)during sickle cell crisis (pain or acute chest syndrome). This study will evaluate the role of hemolysis during SCD crisis on the development of AKI and the role for monitoring urine biomarkers during an admission for cris...
What is the current status of trial NCT03105271?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2017-01-01. Estimated completion is 2022-01-31.
Who is sponsoring clinical trial NCT03105271?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI